1-9 of 9
Jeffrey A. Sosman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Features of Acquired Resistance to Anti–PD-1 Therapy in Advanced Melanoma

Daniel Y. Wang, Zeynep Eroglu, Alpaslan Ozgun, Paul D. Leger, Shilin Zhao, Fei Ye, Jason J. Luke, Richard W. Joseph, Rizwan Haq, Patrick A. Ott, F. Stephen Hodi, Jeffrey A. Sosman, Douglas B. Johnson, Elizabeth I. Buchbinder
Journal: Cancer Immunology Research
Cancer Immunol Res (2017) 5 (5): 357–362.
https://doi.org/10.1158/2326-6066.CIR-16-0287
Published: 01 May 2017
View article titled, Clinical Features of Acquired Resistance to Anti–PD-1 Therapy in Advanced Melanoma
Open the PDF for Clinical Features of Acquired Resistance to Anti–PD-1 Therapy in Advanced Melanoma in another window
Includes: Supplementary data
Journal Articles

Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade

Douglas B. Johnson, Garrett M. Frampton, Matthew J. Rioth, Erik Yusko, Yaomin Xu, Xingyi Guo, Riley C. Ennis, David Fabrizio, Zachary R. Chalmers, Joel Greenbowe, Siraj M. Ali, Sohail Balasubramanian, James X. Sun, Yuting He, Dennie T. Frederick, Igor Puzanov, Justin M. Balko, Justin M. Cates, Jeffrey S. Ross, Catherine Sanders, Harlan Robins, Yu Shyr, Vincent A. Miller, Philip J. Stephens, Ryan J. Sullivan, Jeffrey A. Sosman, Christine M. Lovly
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (11): 959–967.
https://doi.org/10.1158/2326-6066.CIR-16-0143
Published: 31 October 2016
View article titled, Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade
Open the PDF for Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade in another window
Includes: Supplementary data
Journal Articles

Abstract A064: IDO1 expression stratifies glioblastoma patient survival and correlates with dominantly immunosuppressive pathways

Lijie Zhai, Matthew Genet, Erik Ladomersky, Kristen Lauing, Meijing Wu, David Binder, Leo Kim, Jeremy Rich, Craig Horbinski, C. David James, Jeffrey A. Sosman, Orin Bloch, Derek A. Wainwright
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (11_Supplement): A064.
https://doi.org/10.1158/2326-6066.IMM2016-A064
Published: 31 October 2016
View article titled, Abstract A064: IDO1 expression stratifies glioblastoma patient survival and correlates with dominantly immunosuppressive pathways
Journal Articles

Prolonged Benefit from Ipilimumab Correlates with Improved Outcomes from Subsequent Pembrolizumab

Amanda Shreders, Richard Joseph, Chengwei Peng, Fei Ye, Shilin Zhao, Igor Puzanov, Jeffrey A. Sosman, Douglas B. Johnson
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (7): 569–573.
https://doi.org/10.1158/2326-6066.CIR-15-0281
Published: 30 June 2016
View article titled, Prolonged Benefit from Ipilimumab Correlates with Improved Outcomes from Subsequent Pembrolizumab
Open the PDF for Prolonged Benefit from Ipilimumab Correlates with Improved Outcomes from Subsequent Pembrolizumab in another window
Includes: Supplementary data
Journal Articles

Myelodysplastic Syndrome Revealed by Systems Immunology in a Melanoma Patient Undergoing Anti–PD-1 Therapy

Allison R. Greenplate, Douglas B. Johnson, Mikael Roussel, Michael R. Savona, Jeffrey A. Sosman, Igor Puzanov, P. Brent Ferrell, Jr, Jonathan M. Irish
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (6): 474–480.
https://doi.org/10.1158/2326-6066.CIR-15-0213
Published: 31 May 2016
View article titled, Myelodysplastic Syndrome Revealed by Systems Immunology in a Melanoma Patient Undergoing Anti–PD-1 Therapy
Open the PDF for Myelodysplastic Syndrome Revealed by Systems Immunology in a Melanoma Patient Undergoing Anti–PD-1 Therapy in another window
Includes: Supplementary data
Journal Articles

Survivorship in Immune Therapy: Assessing Chronic Immune Toxicities, Health Outcomes, and Functional Status among Long-term Ipilimumab Survivors at a Single Referral Center

Douglas B. Johnson, Debra L. Friedman, Elizabeth Berry, Ilka Decker, Fei Ye, Shilin Zhao, Alicia K. Morgans, Igor Puzanov, Jeffrey A. Sosman, Christine M. Lovly
Journal: Cancer Immunology Research
Cancer Immunol Res (2015) 3 (5): 464–469.
https://doi.org/10.1158/2326-6066.CIR-14-0217
Published: 03 May 2015
View article titled, Survivorship in Immune Therapy: Assessing Chronic Immune Toxicities, Health Outcomes, and Functional Status among Long-term Ipilimumab Survivors at a Single Referral Center
Open the PDF for Survivorship in Immune Therapy: Assessing Chronic Immune Toxicities, Health Outcomes, and Functional Status among Long-term Ipilimumab Survivors at a Single Referral Center in another window
Journal Articles

Impact of NRAS Mutations for Patients with Advanced Melanoma Treated with Immune Therapies

Douglas B. Johnson, Christine M. Lovly, Marisa Flavin, Katherine S. Panageas, Gregory D. Ayers, Zhiguo Zhao, Wade T. Iams, Marta Colgan, Sarah DeNoble, Charles R. Terry, Elizabeth G. Berry, A. John Iafrate, Ryan J. Sullivan, Richard D. Carvajal, Jeffrey A. Sosman
Journal: Cancer Immunology Research
Cancer Immunol Res (2015) 3 (3): 288–295.
https://doi.org/10.1158/2326-6066.CIR-14-0207
Published: 02 March 2015
View article titled, Impact of NRAS Mutations for Patients with Advanced Melanoma Treated with Immune Therapies
Open the PDF for Impact of NRAS Mutations for Patients with Advanced Melanoma Treated with Immune Therapies in another window
Includes: Supplementary data
Journal Articles

Adjuvant Vaccine Immunotherapy of Resected, Clinically Node-Negative Melanoma: Long-term Outcome and Impact of HLA Class I Antigen Expression on Overall Survival

William E. Carson, III, Joseph M. Unger, Jeffrey A. Sosman, Lawrence E. Flaherty, Ralph J. Tuthill, Mark J. Porter, John A. Thompson, Raymond A. Kempf, Megan Othus, Antoni Ribas, Vernon K. Sondak
Journal: Cancer Immunology Research
Cancer Immunol Res (2014) 2 (10): 981–987.
https://doi.org/10.1158/2326-6066.CIR-14-0052
Published: 02 October 2014
View article titled, Adjuvant Vaccine Immunotherapy of Resected, Clinically Node-Negative Melanoma: Long-term Outcome and Impact of HLA Class I Antigen Expression on Overall Survival
Open the PDF for Adjuvant Vaccine Immunotherapy of Resected, Clinically Node-Negative Melanoma: Long-term Outcome and Impact of HLA Class I Antigen Expression on Overall Survival in another window
Journal Articles

Severe Cutaneous and Neurologic Toxicity in Melanoma Patients during Vemurafenib Administration Following Anti-PD-1 Therapy

Douglas B. Johnson, Erika K. Wallender, Daniel N. Cohen, Sunaina S. Likhari, Jeffrey P. Zwerner, Jennifer G. Powers, Lisa Shinn, Mark C. Kelley, Richard W. Joseph, Jeffrey A. Sosman
Journal: Cancer Immunology Research
Cancer Immunol Res (2013) 1 (6): 373–377.
https://doi.org/10.1158/2326-6066.CIR-13-0092
Published: 05 December 2013
View article titled, Severe Cutaneous and Neurologic Toxicity in Melanoma Patients during Vemurafenib Administration Following Anti-PD-1 Therapy
Open the PDF for Severe Cutaneous and Neurologic Toxicity in Melanoma Patients during Vemurafenib Administration Following Anti-PD-1 Therapy in another window